BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Schrödinger and WuXi AppTec Announce the Launch of Faxian Therapeutics to Enable Accelerated Drug Discovery

  The new venture will leverage the precision molecular design platforms developed by Schrödinger and accelerate them through partnership with the world-class lead optimization services provided by WuXi AppTec.

  October 30, 2018

   · 

  3 min read
• Montreal 18 Physiotherapy Congress

  Canadian physiotherapy professionals concerned by the opioid crisis

  October 30, 2018

   · 

  1 min read
• BioForest

  Sirona Dx Launches Novel Urine-Based Bladder Cancer Assay with PD-L1 Quantification Based on IncellDx’s Single Cell Immuno-Oncology/PD-L1 Technology

  Sirona Dx announced today the launch of Oncocyst PD-L1, an assay using IncellDx technology that detects and quantifies abnormal bladder cells and immune cells from urine cytology specimens that express the immune-oncology marker PD-L1 using multi-parameter flow cytometry and bioinformatics.

  October 30, 2018

   · 

  2 min read
• Business

  Dr. Andrew C. Von Eschenbach Joins Bausch Health Board Of Directors

  Bausch Health Companies Inc. today announced its board of directors has elected Dr. Andrew C. von Eschenbach to serve as a director, effective Oct. 29, 2018.

  October 30, 2018

   · 

  4 min read